Neuro/Psych pharmacology - Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial

Psychiatry April 03, 2015 Smartest Doc Articles Career Center Clinical Trials Conferences Sponsor Messages include industry-sponsored communications and special communications from MDLinx Learn about a therapy option from Lilly for adult patients with type 2 diabetes. Eli Lilly and Company Your Smartest Doc Challenge for April Smartest Doc Challenge, MDLinx Syndecan-1 is a marker for IBD D Scott Cunningham MD, PhD, MDLinx Articles: Neuro/Psych Pharmacol Ranked, sorted, and summarized by MDLinx editors from the latest literature. 2 new articles from 121 contributor journals scanned today. (see the list) Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial Journal of the Formosan Medical Association   ||   Extended Summary Increased interleukin 23 (IL23) levels in schizophrenia patients treated with depot antipsychotic medication Cytokine   ||   Extended Summary Sponsor Top Read Articles This Month Effects of 10 to 30 years of lithium treatment on kidney function Journal of Psychopharmacology Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers Neuropsychiatric Disease and Treatment Serotonin–norepinephrine reuptake inhibitor and selective serotonin reuptake inhibitor use and risk of fractures: A new-user cohort study among US adults aged 50 years and older CNS Drugs Comparative efficacy and acceptability of atomoxetine, lisdexamfetamine, bupropion and methylphenidate in treatment of attention deficit hyperactivity disorder in children and adolescents: A meta-analysis with focus on bupropion Journal of Affective Disorders Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: A randomized clinical trial JAMA Psychiatry Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: A randomized comparative effectiveness trial of optimized personalized treatment with and without lithium FOCUS Vortioxetine, a multimodal antidepressant for generalized anxiety disorder: A systematic review and meta-analysis Journal of Psychiatric Research The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer FOCUS Effect of comedication of bupropion and other antidepressants on body mass index Therapeutic Advances in Psychopharmacology Naltrexone vs placebo for the treatment of alcohol dependence: A randomized clinical trial JAMA Psychiatry Escitalopram in the prevention of posttraumatic stress disorder: A pilot randomized controlled trial BMC Psychiatry More Messages Hot Topic: Traditional Chinese medicine MDLinx Top Read, MDLinx Sponsor Sponsor

Topics in Psychiatry Anxiety Child/Adolescent Psych Eating Disorders Geriatric Psych Mood Disorders Neuro/Psych Pharmacol Neuropsych Sciences Other Psychiatry Pain Management Personality Disorders Popular Press Psychotherapy/analysis Schizophrenia/Psychosis Smartest Psychiatrist Quiz Substance Abuse Teaching Hospital News